
吉非替尼/厄洛替尼致间质性肺疾病患者的临床特点及预后
刘晓琦; 杨敏
吉非替尼/厄洛替尼致间质性肺疾病患者的临床特点及预后
Clinical characteristics and prognosis of patients with interstitial lung disease induced by gefitinib or erlotinib
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |